Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone Jun 29, 2017
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jun 23, 2017
Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China Jun 22, 2017 Life Science
DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma (“GBM”) at SNO’s Pediatric Neuro-Oncology Basic and Translational Research Conference Jun 17, 2017 Life Science
RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection Jun 15, 2017 Life Science
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug Jun 14, 2017 Life Science
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S Jun 14, 2017 Life Science
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis Jun 14, 2017 Life Science
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map Jun 14, 2017 Life Science
